UROLOGICAL CANCER Chemoradiation superior in muscle-invasive bladder cancer

被引：2
|
作者：
Weiss, Christian [1 ]
Roedel, Claus [1 ]
机构：
[1] Goethe Univ Frankfurt, Dept Radiat Therapy & Oncol, D-60590 Frankfurt, Germany
来源：
NATURE REVIEWS CLINICAL ONCOLOGY | 2012年 / 9卷 / 07期
关键词：
SELECTIVE ORGAN PRESERVATION; RADICAL CYSTECTOMY; RADIOTHERAPY; CHEMOTHERAPY; EXPERIENCE; THERAPY;
D O I：
10.1038/nrclinonc.2012.92
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Multimodal organ-sparing treatment strategies have shown similar survival rates when compared to radical surgery for muscle-invasive bladder cancer; however, up to 80% of surviving patients retained their own, well-functioning bladder. Within an interdisciplinary bladder-preserving treatment protocol, concurrent chemoradiotherapy was superior to radiotherapy alone-supporting its use as an alternative to radical cystectomy. © 2012 Macmillan Publishers Limited. All rights reserved.
引用
收藏
页码：374 / 375
页数：3
相关论文
共 50 条
  • [1] Bladder conservation for muscle-invasive bladder cancer
    Hoskin, Peter
    Dubash, Suraiya
    EXPERT REVIEW OF ANTICANCER THERAPY, 2012, 12 (08) : 1015 - 1020
  • [2] Chemoradiation for organ preservation in the treatment of muscle-invasive bladder cancer
    McHaffie, Derek R.
    Kruser, Tim J.
    Gaston, Kris
    Mahoney, John
    Graham, David
    Haake, Michael
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2016, 34 (06) : 271 - 278
  • [3] Bladder preservation by neoadjuvant chemotherapy followed by concurrent chemoradiation for muscle-invasive bladder cancer
    Elsayed, Dalia Hamouda
    Elfarargy, Ola M.
    Elderey, Mohamed Salah
    Mandour, Doaa
    Atef, Nora
    Hemeda, Rehab
    Kamel, Mostafa
    Azony, Ahmed
    Taha, Heba F.
    WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2023, 27 (01): : 1 - 9
  • [4] Current management of muscle-invasive bladder cancer
    Sancho, Gemma
    Maroto, Pablo
    Palou, Joan
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2011, 13 (12) : 855 - 861
  • [5] Muscle-invasive bladder cancer
    Buchler, Jakob
    Gschwend, Juergen E.
    Retz, Margitta
    Schmid, Sebastian C.
    UROLOGE, 2021, 60 (06): : 769 - 775
  • [6] The treatment of muscle-invasive bladder cancer in geriatric patients
    Grubmueller, Bernhard
    Seitz, Christian
    Shariat, Shahrokh F.
    CURRENT OPINION IN UROLOGY, 2016, 26 (02) : 160 - 164
  • [7] Bladder sparing options for muscle-invasive bladder cancer
    Laukhtina, Ekaterina
    Moschini, Marco
    Teoh, Jeremy Yuen-Chun
    Shariat, Shahrokh F.
    CURRENT OPINION IN UROLOGY, 2024, 34 (06) : 471 - 476
  • [8] Canadian Urological Association guideline: Muscle-invasive bladder cancer
    Kulkarni, Girish S.
    Black, Peter C.
    Sridhar, Srikala S.
    Kapoor, Anil
    Zlotta, Alexandre R.
    Shayegan, Bobby
    Rendon, Ricardo A.
    Chung, Peter
    van der Kwast, Theodorus
    Alimohamed, Nimira
    Fradet, Yves
    Kassouf, Wassim
    CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2019, 13 (08): : 230 - 238
  • [9] Outcomes by time to definitive chemoradiation treatment for patients with muscle-invasive bladder cancer
    Kotha, Nikhil V.
    Kumar, Abhishek
    Nelson, Tyler J.
    Qiao, Edmund M.
    Qian, Alex S.
    Voora, Rohith S.
    Mckay, Rana R.
    Rose, Brent S.
    Stewart, Tyler F.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2022, 40 (06) : 274.e1 - 274.e6
  • [10] Sensitivity to chemoradiation predicts development of metastasis in muscle-invasive bladder cancer patients
    Koga, Fumitaka
    Numao, Noboru
    Saito, Kazutaka
    Masuda, Hitoshi
    Fujii, Yasuhisa
    Kawakami, Satoru
    Kihara, Kazunori
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2013, 31 (07) : 1270 - 1275
12345